| CAS NO: | 526-06-7 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 生物活性 | Eudesmin ((-)-Eudesmin) impairs adipogenic differentiation via inhibition ofS6K1signaling pathway. Eudesmin possesses diverse therapeutic effects, including anti-tumor, anti-inflammatory, and anti-bacterial activities[1]. | ||||||||||||||||
| IC50& Target | S6K1[1] | ||||||||||||||||
| 体外研究 (In Vitro) | Treatment of mesenchymal stem cells (MSCs) with Eudesmin (20, 40, and 80μM) disturbs adipogenesis via suppression of S6K1 signaling pathway. Eudesmin treatment inhibits activation and nuclear translocation of S6K1. S6K1-mediated phosphorylation of H2B at serine 36 (H2BS36p) is reduced upon Eudesmin treatment[1]. | ||||||||||||||||
| 分子量 | 386.44 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C22H26O6 | ||||||||||||||||
| CAS 号 | 526-06-7 | ||||||||||||||||
| 中文名称 | 桉脂素 | ||||||||||||||||
| 结构分类 |
| ||||||||||||||||
| 来源 |
| ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 100 mg/mL(258.77 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
